Variant report

Variant	rs201195
Chromosome Location	chr3:50638782-50638783
allele	A/C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:50373496..50376492-chr3:50637687..50640592,4	K562	blood:
2	chr3:50626963..50632967-chr3:50633102..50640850,17	K562	blood:
3	chr3:50599337..50613537-chr3:50634306..50660129,118	MCF-7	breast:
4	chr3:50613663..50623986-chr3:50635558..50652363,41	MCF-7	breast:
5	chr3:50596509..50599002-chr3:50637858..50640256,2	MCF-7	breast:
6	chr3:50638594..50639295-chr3:50648738..50649367,2	MCF-7	breast:
7	chr3:50382035..50386464-chr3:50636911..50639420,4	MCF-7	breast:
8	chr3:50373496..50376047-chr3:50637819..50639325,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000114735	Chromatin interaction
ENSG00000114388	Chromatin interaction
ENSG00000004838	Chromatin interaction
ENSG00000068028	Chromatin interaction
ENSG00000114737	Chromatin interaction
ENSG00000114738	Chromatin interaction
ENSG00000088543	Chromatin interaction

Extended variants
information (count: 26 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:15)

rs_ID	r²[population]
rs1905516	1.00[AMR][1000 genomes]
rs2249775	1.00[AMR][1000 genomes]
rs2355339	1.00[AMR][1000 genomes]
rs2609009	1.00[AMR][1000 genomes]
rs2675780	1.00[AMR][1000 genomes]
rs2675805	1.00[AMR][1000 genomes]
rs388195	1.00[AMR][1000 genomes]
rs414856	1.00[AMR][1000 genomes]
rs4234696	1.00[AMR][1000 genomes]
rs4688706	1.00[AMR][1000 genomes]
rs608961	1.00[AMR][1000 genomes]
rs6779405	1.00[AMR][1000 genomes]
rs6790086	1.00[AMR][1000 genomes]
rs7629126	1.00[AMR][1000 genomes]
rs9854316	1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:11 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
2	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
3	esv3584502	chr3:50368278-50659741	Strong transcription Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	55 gene(s)	inside rSNPs	diseases
4	nsv1013225	chr3:50440826-50700448	Flanking Active TSS Enhancers Genic enhancers Weak transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
5	nsv536566	chr3:50440826-50700448	Genic enhancers Weak transcription Flanking Active TSS Enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
6	nsv984540	chr3:50473691-50669310	Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
7	nsv1012501	chr3:50483037-50679591	Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
8	nsv536567	chr3:50483037-50679591	Bivalent Enhancer Strong transcription Flanking Active TSS Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
9	nsv460533	chr3:50574213-50678151	Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Active TSS Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	25 gene(s)	inside rSNPs	diseases
10	nsv590273	chr3:50574213-50678151	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	25 gene(s)	inside rSNPs	diseases
11	esv3425095	chr3:50638568-50638833	Flanking Active TSS Enhancers Weak transcription Genic enhancers	Chromatin interactive region	7 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:112 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50635600-50638800	Enhancers	Colon Smooth Muscle	Colon
2	chr3:50635800-50640400	Enhancers	Placenta	Placenta
3	chr3:50636000-50638800	Enhancers	Right Ventricle	heart
4	chr3:50636000-50641200	Enhancers	Lung	lung
5	chr3:50636000-50641400	Enhancers	Fetal Thymus	thymus
6	chr3:50636000-50641600	Enhancers	Esophagus	oesophagus
7	chr3:50636200-50638800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
8	chr3:50636200-50639000	Enhancers	Liver	Liver
9	chr3:50636200-50640600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
10	chr3:50636400-50638800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
11	chr3:50636400-50640600	Enhancers	Right Atrium	heart
12	chr3:50636400-50641000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr3:50636400-50641600	Enhancers	Pancreas	Pancrea
14	chr3:50636600-50638800	Enhancers	Fetal Intestine Large	intestine
15	chr3:50636600-50638800	Enhancers	Fetal Muscle Trunk	muscle
16	chr3:50636600-50639000	Enhancers	Breast Myoepithelial Primary Cells	Breast
17	chr3:50636600-50639200	Enhancers	Fetal Muscle Leg	muscle
18	chr3:50636600-50639600	Enhancers	Spleen	Spleen
19	chr3:50636600-50640400	Enhancers	Primary monocytes fromperipheralblood	blood
20	chr3:50636600-50640600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
21	chr3:50636600-50643600	Enhancers	Left Ventricle	heart
22	chr3:50636800-50640600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
23	chr3:50636800-50641600	Enhancers	Gastric	stomach
24	chr3:50636800-50646000	Genic enhancers	Fetal Intestine Small	intestine
25	chr3:50637000-50638800	Enhancers	HSMM	muscle
26	chr3:50637000-50639000	Enhancers	Fetal Lung	lung
27	chr3:50637000-50639800	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
28	chr3:50637000-50640400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
29	chr3:50637000-50640400	Enhancers	Brain Angular Gyrus	brain
30	chr3:50637000-50640800	Enhancers	Primary hematopoietic stem cells	blood
31	chr3:50637200-50638800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
32	chr3:50637200-50638800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
33	chr3:50637200-50638800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr3:50637200-50638800	Enhancers	Duodenum Mucosa	Duodenum
35	chr3:50637200-50638800	Enhancers	A549	lung
36	chr3:50637200-50638800	Enhancers	NHDF-Ad	bronchial
37	chr3:50637200-50639000	Enhancers	Adipose Nuclei	Adipose
38	chr3:50637200-50639000	Enhancers	NHLF	lung
39	chr3:50637200-50640200	Enhancers	Primary B cells from peripheral blood	blood
40	chr3:50637200-50640400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
41	chr3:50637400-50638800	Enhancers	Stomach Mucosa	stomach
42	chr3:50637400-50638800	Enhancers	Osteobl	bone
43	chr3:50637400-50639000	Enhancers	Fetal Kidney	kidney
44	chr3:50637400-50639800	Flanking Active TSS	K562	blood
45	chr3:50637400-50640000	Enhancers	Brain Substantia Nigra	brain
46	chr3:50637400-50640200	Enhancers	Psoas Muscle	Psoas
47	chr3:50637400-50640600	Flanking Active TSS	Dnd41	blood
48	chr3:50637600-50638800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
49	chr3:50637600-50638800	Enhancers	Muscle Satellite Cultured Cells	--
50	chr3:50637600-50639000	Enhancers	Brain Anterior Caudate	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links